Article
Clinical trajectories and medication response in TBC1D24-related epilepsies.
Epilepsia - 1 Mar 2026
Mondragon Ealing, Magielski Jan H, Bane Bintou, Nolan JoeyLynn, Ruggiero Sarah M, Armstrong Dallas, Arnold Susan, Sirsi Deepa, Helbig Ingo, McKee Jillian L
Abstract excerpt
OBJECTIVE: Biallelic variants in TBC1D24 represent a rare cause of epilepsy and neurodevelopmental disorders, including severe developmental and epileptic encephalopathies. Here, we present the first attempt to delineate the longitudinal disease histories and effectiveness of antiseizure medications (ASMs) in TBC1D24-related disorders. METHODS: We performed an analysis of the electronic medical record data of 15...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
